KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $23.0 million.

  • Johnson & Johnson's Exchange Rate Effect rose 11161.62% to $23.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $201.0 million, marking a year-over-year increase of 16955.02%. This contributed to the annual value of $201.0 million for FY2025, which is 16955.02% up from last year.
  • As of Q4 2025, Johnson & Johnson's Exchange Rate Effect stood at $23.0 million, which was up 11161.62% from -$46.0 million recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Exchange Rate Effect registered a high of $224.0 million during Q1 2021, and its lowest value of -$198.0 million during Q4 2024.
  • Its 5-year average for Exchange Rate Effect is -$15.1 million, with a median of -$15.0 million in 2022.
  • In the last 5 years, Johnson & Johnson's Exchange Rate Effect crashed by 54642.86% in 2024 and then soared by 28117.65% in 2025.
  • Johnson & Johnson's Exchange Rate Effect (Quarter) stood at -$92.0 million in 2021, then skyrocketed by 117.39% to $16.0 million in 2022, then soared by 681.25% to $125.0 million in 2023, then tumbled by 258.4% to -$198.0 million in 2024, then surged by 111.62% to $23.0 million in 2025.
  • Its Exchange Rate Effect stands at $23.0 million for Q4 2025, versus -$46.0 million for Q3 2025 and $154.0 million for Q2 2025.